EP3349740
CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
:
EP einkaleyfi: Þýðing ekki lögð inn:
13.9.2016:
21.4.2021:
16771043.3
:
12.9.2036
:
CO-THERAPY COMPRISING CANAGLIFLOZIN AND PHENTERMINE FOR USE IN THE TREATMENT OF OBESITY AND OBESITY RELATED DISORDERS
13.9.2016
21.4.2021
:
Janssen Pharmaceutica NV:
Turnhoutseweg 30, 2340 Beerse, BE
:
ROSENTHAL, Norman R.:
Raritan, New Jersey 08869, US
:
ROTHENBERG, Paul:
Raritan, New Jersey 08869, US
:
POLIDORI, David C.:
San Diego, California 92121, US
:
WAYS, Douglas K.:
Raritan, New Jersey 08869, US
:
STEIN, Peter P.:
Princeton, New Jersey 08550, US
:
201562218842 P:
15.9.2015:
US
:
201662306110 P:
10.3.2016:
US
:
201615262038:
12.9.2016:
US
:
US2016051435:
13.9.2016
:
A61K 31/137, A61K 31/7042, A61P 3/04, A61P 3/00, A61P 9/00, A61P 9/12, A61P 13/00, A61P 1/16, A61P 43/00